Search Results - Mario Mandala

Refine Results
  1. 1

    Melanoma brain metastases: review of histopathological features and immune-molecular aspects by Lorenzo Salvati, Mario Mandalà, Daniela Massi

    Published in Melanoma Management (2020-07-01)
    Get full text
    Article


  2. 2

    Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont et al by James Larkin, Jeffrey Weber, Paolo Antonio Ascierto, Mario Mandala

    Published in Journal for ImmunoTherapy of Cancer (2022-01-01)
    Get full text
    Article


  3. 3

    Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications by Alice Indini, Francesco Grossi, Mario Mandalà, Daniela Taverna, Valentina Audrito

    Published in Biomedicines (2021-05-01)
    Get full text
    Article


  4. 4

    Adjuvant systemic therapy in melanoma: Relative versus absolute benefit; the number needed to treat (NNT) versus the number needed to harm (NNH)? by Alexander C.J. van Akkooi, Mario Mandala, Paul Nathan, Andrew Haydon, Michael Postow, Piotr Rutkowski

    Published in EJC Skin Cancer (2024-12-01)
    Get full text
    Article


  5. 5

    Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAFv600e mutated melanoma cells in vitro by Cristian Scatena, Sara Franceschi, Maria Franzini, Chiara Sanguinetti, Nadia Romiti, Laura Caponi, Mario Mandalà, Chiara Maria Mazzanti, Antonio Giuseppe Naccarato

    Published in Cancer Cell International (2019-08-01)
    Get full text
    Article


  6. 6

    Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients by Francesco De Logu, Francesca Galli, Romina Nassini, Filippo Ugolini, Sara Simi, Mara Cossa, Clelia Miracco, Andrea Gianatti, Vincenzo De Giorgi, Eliana Rulli, Antonio Cossu, Daniela Massi, Mario Mandalà

    Published in Cells (2021-02-01)
    Get full text
    Article


  7. 7

    Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective by Maria Neve Ombra, Panagiotis Paliogiannis, Luigia Stefania Stucci, Maria Colombino, Milena Casula, Maria Cristina Sini, Antonella Manca, Grazia Palomba, Ignazio Stanganelli, Mario Mandalà, Sara Gandini, Amelia Lissia, Valentina Doneddu, Antonio Cossu, Giuseppe Palmieri, for the Italian Melanoma Intergroup (IMI)

    Published in Nutrition & Metabolism (2019-05-01)
    Get full text
    Article


  8. 8

    Grand SLAM study protocol: a prospective randomised multicentre study of shortened versus standard duration adjuvant immune checkpoint inhibition for stage IIB-C, III and IV cutane... by Patric Ejder, Henrik Jespersen, Micaela Hernberg, Lars Ny, Ana Carneiro, Sander Ellegård, Kalle Mattila, Roger Olofsson Bagge, Georgios Fountoukidis, Yvonne Brandberg, Mario Mandala, Brent O´Carrigan, Bastian Schilling, Ana Aranche, Omid Hamid, Anders Berglund, Hildur Helgadottir, Gustav Ullenhag

    Published in BMC Cancer (2026-03-01)
    Get full text
    Article


  9. 9

    The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022 by Paolo A. Ascierto, Christian Blank, Alexander M. Eggermont, Claus Garbe, Jeffrey E. Gershenwald, Omid Hamid, Axel Hauschild, Jason J. Luke, Janice M. Mehnert, Jeffrey A. Sosman, Hussein A. Tawbi, Mario Mandalà, Alessandro Testori, Corrado Caracò, Iman Osman, Igor Puzanov

    Published in Journal of Translational Medicine (2023-04-01)
    Get full text
    Article


  10. 10

    Morpho-phenotypic characterization of melanoma brain metastases immune microenvironment: A multicentre retrospective study by Filippo Nozzoli, Marco Gessi, Filippo Ugolini, Sara Simi, Luca Tinunin, Luigi Francesco Iannone, Alice Esposito, Giovanni Muscas, Alessandro Della Puppa, Isabella Ciardetti, Nicola Pimpinelli, Vincenzo De Giorgi, Isacco Desideri, Lorenzo Livi, Laura Doni, Giovanni Schinzari, Ernesto Rossi, Mario Mandalà, Daniela Massi

    Published in EJC Skin Cancer (2024-12-01)
    Get full text
    Article


  11. 11

    Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study by Francesca Corti, Jacopo Pigozzo, Eliana Rulli, Piotr Rutkowski, Carlo Alberto Tondini, Iwona Lugowska, Alice Indini, Matilde De Luca, Barbara Merelli, Anna Mariuk-Jarema, Pawel Teterycz, Pawel Rogala, Bożena Cybulska-Stopa, Alice Labianca, Lorenza Di Guardo, Michele Del Vecchio, Giovanni Randon, Mario Mandala

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  12. 12

    Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, contro... by Kohei Shitara, Kei Muro, Razvan Cristescu, Michael Nebozhyn, Andrey Loboda, Hyun Cheol Chung, Wasat Mansoor, Mustafa Ozguroglu, Mario Mandala, Maria Di Bartolomeo, Christian Caglevic, Julie Kobie, Min-Hee Ryu, Z Alexander Cao, Tomasz Olesinski, Eray Goekkurt, Raymond S McDermott, Zev A Wainberg, Chie-Schin Shih

    Published in Journal for ImmunoTherapy of Cancer (2023-06-01)
    Get full text
    Article


  13. 13

    Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM) by José Luis Manzano, Ivan Marquez-Rodas, Cristina Carrera, Mario Mandala, Eva Muñoz-Couselo, Maria Gonzalez-Cao, Teresa Puertolas, Mar Riveiro, Carolina Ortiz, Roger Paredes, Daniel Podzamczer, Jose Molto, Boris Revollo, Lourdes Mateu, Sara Fancelli, Enrique Espinosa, Bonaventura Clotet, Javier Martinez-Picado, Pablo Cerezuela, Ainara Soria, Alfonso Berrocal

    Published in Journal for ImmunoTherapy of Cancer (2021-03-01)
    Get full text
    Article


  14. 14

    Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases by Maria A. Pizzichetta, Daniela Massi, Mario Mandalà, Paola Queirolo, Ignazio Stanganelli, Vincenzo De Giorgi, Giovanni Ghigliotti, Stefano Cavicchini, Pietro Quaglino, Maria T. Corradin, Pietro Rubegni, Mauro Alaibac, Stefano Astorino, Fabrizio Ayala, Serena Magi, Laura Mazzoni, Maria Ausilia Manganoni, Renato Talamini, Diego Serraino, Giuseppe Palmieri, on behalf of the Italian Melanoma Intergroup (IMI)

    Published in Journal of Translational Medicine (2017-11-01)
    Get full text
    Article


  15. 15

    An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival by Francesco Mannavola, Mario Mandala, Annalisa Todisco, Vanna Chiarion Sileni, Marco Palla, Alessandro Marco Minisini, Laura Pala, Francesca Morgese, Lorenza Di Guardo, Luigia Stefania Stucci, Michele Guida, Alice Indini, Pietro Quaglino, Virginia Ferraresi, Riccardo Marconcini, Maria Chiara Tronconi, Ernesto Rossi, Olga Nigro, Marcella Occelli, Alessio Cortellini, Silvia Quadrini, Giuseppe Palmieri, Jacopo Pigozzo, Paolo Antonio Ascierto, Maria Grazia Vitale, Sabino Strippoli, Pier Francesco Ferrucci, Rossana Berardi, Giovanni Randon, Pietro Cardone, Giovanni Schinzari, Franco Silvestris, Marco Tucci, Marco Tucci

    Published in Frontiers in Oncology (2020-09-01)
    Get full text
    Article


  16. 16

    Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma by Emanuel Bührer, Nina Glassee, Michal Kicinski, Oliver J. Kennedy, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Sara Gandini, Sara Valpione, Stefan Suciu, Caroline Robert, Alexander M.M. Eggermont, Paul Lorigan, Mario Mandala

    Published in EJC Skin Cancer (2025-01-01)
    Get full text
    Article


  17. 17

    Prognostic and predictive importance of body mass index and type 2 diabetes in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pe... by Oliver John Kennedy, Nina Glassee, Michal Kicinski, Emanuel Bührer, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Caroline Robert, Alexander M.M. Eggermont, Paul Lorigan, Mario Mandala

    Published in EJC Skin Cancer (2025-01-01)
    Get full text
    Article


  18. 18

    Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial by Paolo A. Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Rutkowski, Virginia Ferraresi, Ana Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbe, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F. Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero, Antonio M. Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri

    Published in Nature Communications (2024-01-01)
    Get full text
    Article


  19. 19

    Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort stu... by Xue Bai, Ahmed Shaheen, Charlotte Grieco, Paolo D. d’Arienzo, Florentia Mina, Juliane A. Czapla, Aleigha R. Lawless, Eleonora Bongiovanni, Umberto Santaniello, Helena Zappi, Dominika Dulak, Andrew Williamson, Rebecca Lee, Avinash Gupta, Caili Li, Lu Si, Martina Ubaldi, Naoya Yamazaki, Dai Ogata, Rebecca Johnson, Benjamin C. Park, Seungyeon Jung, Gabriele Madonna, Juliane Hochherz, Yoshiyasu Umeda, Yasuhiro Nakamura, Christoffer Gebhardt, Lucia Festino, Mariaelena Capone, Paolo Antonio Ascierto, Douglas B. Johnson, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies, Kenjiro Namikawa, Mario Mandala, Jun Guo, Paul Lorigan, Yana G. Najjar, Andrew Haydon, Pietro Quaglino, Genevieve M. Boland, Ryan J. Sullivan, Andrew J.S. Furness, Ruth Plummer, Keith T. Flaherty

    Published in EClinicalMedicine (2024-05-01)
    Get full text
    Article


  20. 20

    Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort stu... by Xue Bai, Ahmed Shaheen, Charlotte Grieco, Paolo D. d’Arienzo, Florentia Mina, Juliane A. Czapla, Aleigha R. Lawless, Eleonora Bongiovanni, Umberto Santaniello, Helena Zappi, Dominika Dulak, Andrew Williamson, Rebecca Lee, Avinash Gupta, Caili Li, Lu Si, Martina Ubaldi, Naoya Yamazaki, Dai Ogata, Rebecca Johnson, Benjamin C. Park, Seungyeon Jung, Gabriele Madonna, Juliane Hochherz, Yoshiyasu Umeda, Yasuhiro Nakamura, Christoffer Gebhardt, Lucia Festino, Mariaelena Capone, Paolo Antonio Ascierto, Douglas B. Johnson, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies, Kenjiro Namikawa, Mario Mandala, Jun Guo, Paul Lorigan, Yana G. Najjar, Andrew Haydon, Pietro Quaglino, Genevieve M. Boland, Ryan J. Sullivan, Andrew J.S. Furness, Ruth Plummer, Keith T. Flaherty

    Published in EClinicalMedicine (2023-11-01)
    Get full text
    Article


Search Tools: